The regulatory milestone strengthens the digital pathology platform’s position as an enterprise-ready system. The distinction builds on CaloPix®’s existing CE marking and Health Canada approval, alongside its proven adoption across 100+ European and Canadian healthcare institutions.
The platform’s web-based, zero-footprint architecture eliminates local installation barriers, enabling seamless deployment across multi-site health networks. Its cloud-ready design future-proofs institutions for scalable digital pathology adoption, while features like high-throughput case management, LIS/VNA integration, and built-in telepathology tools directly address operational pain points by reducing diagnostic turnaround times and facilitating remote collaborations.
Image Credit: Tribun Health
